First line drug fro migraine
Reading File
Searching PubMed
"migraine" AND "acute treatment" AND "first line"
Finding Sources
Reading File
Reading File
Reading File
Here is a thorough breakdown of first-line drugs for migraine, organized by attack severity and context:
First-Line Drugs for Migraine
Acute (Abortive) Treatment
Treatment choice depends on attack severity, following a stratified care approach:
1. Mild-to-Moderate Attacks - NSAIDs and Analgesics
These are the first-line drugs for milder attacks and should be tried first:
| Drug | Notes |
|---|---|
| Aspirin | Effective; best taken early in attack |
| Ibuprofen | Well tolerated; commonly used |
| Naproxen | Available combined with sumatriptan |
| Ketorolac | 10-30 mg IV/IM in ED settings |
| Acetaminophen | Useful if NSAIDs are contraindicated |
"If the headaches are mild, the patient may already have learned that aspirin, acetaminophen, or another NSAID will suffice to control the pain and these are considered first-line therapy." - Adams and Victor's Principles of Neurology, 12th Ed.
2. Moderate-to-Severe Attacks - Triptans (Serotonin Agonists) ★ Main First-Line
Triptans are the cornerstone of acute migraine therapy - they abort or markedly reduce severity in ~70% of patients.
Mechanism: 5-HT1B/1D receptor agonists - cause vasoconstriction of intracranial vessels and inhibit release of proinflammatory neuropeptides from the trigeminal nerve system.
| Triptan | Routes | Key Features |
|---|---|---|
| Sumatriptan (prototype) | SC, intranasal, oral (25/50/100 mg) | SC onset ~20 min; oral onset 1-2 hrs |
| Rizatriptan | Oral (5 or 10 mg) | Fast oral onset |
| Zolmitriptan | Oral (2.5 or 5 mg), nasal spray | Good nasal bioavailability |
| Frovatriptan | Oral | Longest half-life (>24 hrs); preferred for menstrual migraine |
| Naratriptan | Oral | Slower onset, fewer side effects |
| Almotriptan | Oral | Good tolerability |
| Eletriptan | Oral | High potency |
Contraindications: Ischemic heart disease, uncontrolled hypertension, basilar/hemiplegic migraine, recent ergotamine use (within 24 hrs).
"These agents rapidly and effectively abort or markedly reduce the severity of migraine headaches in about 70% of patients and are first-line agents in the treatment of acute migraine." - Lippincott Pharmacology
3. Antiemetics (often given with analgesics or triptans)
Important both for nausea control and independent analgesic effect:
| Drug | Dose | Note |
|---|---|---|
| Prochlorperazine | 5-10 mg IV/PR | Strong evidence in ED |
| Metoclopramide | 10 mg IV | Also acts as analgesic |
| Droperidol | 2.5 mg IV/IM | QT prolongation risk |
| Chlorpromazine | 7.5 mg IV | Pretreat with NS for hypotension |
4. Severe/Refractory Attacks - Ergot Alkaloids
- Dihydroergotamine (DHE): 1 mg IV - efficacy similar to sumatriptan; pretreat with antiemetic. Contraindicated in pregnancy, ischemic heart disease, uncontrolled hypertension.
- Ergotamine: Sublingual; use early. Limited by rebound headache risk and vasoconstrictor side effects.
5. Newer Agents (CGRP-Based)
- Gepants (CGRP receptor antagonists): e.g., ubrogepant, rimegepant - an emerging first-line option, especially in patients with cardiovascular contraindications to triptans.
- Ditans (5-HT1F agonists): e.g., lasmiditan - effective without vasoconstriction; useful in cardiovascular-risk patients.
Preventive (Prophylactic) Therapy
Indicated when attacks are frequent (>=4/month) or disabling:
| Class | Drug Examples |
|---|---|
| Beta-blockers | Propranolol, metoprolol (first-line) |
| Tricyclics | Amitriptyline |
| Anticonvulsants | Valproate, topiramate |
| CGRP monoclonal antibodies | Erenumab, fremanezumab (newer, very effective) |
| Calcium channel blockers | Verapamil |
Key Clinical Pearls
- Treat early - triptans and ergots are most effective at attack onset or during aura
- Medication overuse headache: NSAIDs, triptans, and especially opioids can all cause rebound (medication overuse) headache if used >10-15 days/month
- Sumatriptan + naproxen combination is FDA-approved and more effective than either alone
- Triptans are ineffective during aura for prevention but are safe to take then
- If one triptan fails, try another - response is individual
Sources: Adams and Victor's Principles of Neurology 12th Ed.; Lippincott Illustrated Reviews Pharmacology; Tintinalli's Emergency Medicine
Naproxen dosage ?
Finding Sources
Reading File
Reading File
Naproxen Dosage for Migraine
Acute Migraine Attack
| Formulation | Dose | Frequency |
|---|---|---|
| Naproxen sodium (oral) | 500 mg | Single dose at onset |
| Naproxen (oral) | 220-550 mg | Twice daily (bid) |
- The standard acute dose is 500 mg PO at onset of headache
- May be repeated if needed, but limit total daily use to avoid rebound headache
General Dosing Range (from Harrison's & Rosen's)
- Oral: 220-550 mg twice daily (bid)
- For acute attack: 500 mg as a single dose (Rosen's Emergency Medicine)
- Brand names: Aleve (OTC), Anaprox, Naprosyn
Important Notes
- GI upset is the main side effect - take with food or milk
- Risk of medication overuse headache (MOH) if used >10-15 days/month
- Avoid in: peptic ulcer disease, renal insufficiency, third trimester of pregnancy, hypersensitivity to NSAIDs
- Sumatriptan + naproxen sodium (85 mg/500 mg) is an FDA-approved combination product (Treximet) shown to be more effective than either drug alone for moderate-to-severe migraine
"Naproxen sodium 500 mg PO" - Rosen's Emergency Medicine, Table 39.1 "Naproxen 220-550 mg PO bid" - Harrison's Principles of Internal Medicine, 22nd Ed.
Grammar and diagnosis
Here is the corrected FNAC report with grammar fixes and a diagnostic discussion:
Corrected FNAC Report
APL CYTOLOGY - 05/26
Specimen: FNAC from swelling over the right supraclavicular region.
Clinical Details: Painful swelling over the right supraclavicular region for 10 days, soft like dough on palpation, tender.
On Aspiration: Exudative aspirate.
Microscopy - 05/26
Smears show abundant necrotic material containing degenerated cells, karyorrhectic debris along with a mixed inflammatory infiltrate composed of neutrophils and occasional lymphocytes.
Due to the dense necrosis, no epithelioid cells or granulomas are seen.
There is no evidence of atypia or malignancy in the present smears.
ZN STAIN: Negative for acid-fast bacilli.
Impression:
FNAC from right supraclavicular lymph node: Purulent Abscess.
Note: The possibility of tubercular aetiology cannot be ruled out.
Advice: CBNAAT (GeneXpert) for further evaluation.
Grammar Corrections Made
| Original | Corrected | Reason |
|---|---|---|
| "Smears shows" | "Smears show" | Subject-verb agreement (plural subject) |
| "karyorrhectic" (misspelled as karyorrhectic - underlined in doc) | karyorrhectic | Correct spelling confirmed |
| "Nuetrophils" | "Neutrophils" | Spelling error |
| "epithelioid" (underlined in doc) | epithelioid | Correct spelling |
| "in the present given smears" | "in the present smears" | Redundant word - "present" and "given" are repetitive |
| "Negative for acid fast bacilli" | "Negative for acid-fast bacilli" | Hyphen needed in compound adjective |
| "for further" (shown as "surther" possibly due to cursor) | "for further" | Typographic correction |
Diagnostic Discussion
This FNAC report points to suppurative (purulent) lymphadenitis with the differential of tuberculous lymphadenitis that cannot be excluded.
Key Cytological Findings & Their Significance
| Finding | Significance |
|---|---|
| Exudative aspirate | Indicates pus/suppuration - active infection/inflammation |
| Abundant necrotic material | Hallmark of either pyogenic abscess OR caseous necrosis of TB |
| Karyorrhectic debris | Nuclear fragmentation - seen in both suppurative and TB lymphadenitis |
| Mixed infiltrate - neutrophils + lymphocytes | Suggests bacterial/pyogenic process primarily |
| No epithelioid cells or granulomas | Dense necrosis may be obscuring granulomas; does NOT exclude TB |
| ZN stain negative for AFB | TB not confirmed but NOT excluded - sensitivity of ZN is only ~30-40% in FNAC |
Why TB Cannot Be Ruled Out
- TB lymphadenitis can present as a cold abscess - soft, fluctuant, non-tender - but can also be tender
- The classic finding of epithelioid granulomas with Langerhans giant cells may be completely obscured when there is extensive caseation/necrosis
- ZN stain has low sensitivity (~30%) for Mycobacterium tuberculosis in FNAC specimens
- Supraclavicular lymphadenopathy is a well-known site for tuberculous lymphadenitis in endemic regions
- CBNAAT (GeneXpert MTB/RIF) is the gold standard next step - sensitivity ~80-90% on lymph node aspirate, also detects rifampicin resistance
Differential Diagnosis
- Pyogenic abscess - most likely based on cytology (neutrophil-dominant, acute onset 10 days)
- Tuberculous lymphadenitis - must be excluded given endemic setting and necrotic pattern
- Non-tuberculous mycobacterial (NTM) infection - less common
- Metastatic carcinoma with necrosis - excluded by absence of malignant cells
Recommended Workup
- CBNAAT/GeneXpert on aspirate (as advised) - priority
- Culture and sensitivity if pyogenic organism suspected
- Chest X-ray for pulmonary TB
- Mantoux test / IGRA (e.g., QuantiFERON)
- If CBNAAT negative and clinical suspicion remains high - excision biopsy for histopathology
This is a shared conversation. Sign in to Orris to start your own chat.